s ændring i HbA1c ved 6 måneder - 0, 8 for rimonabant 20 mg og - 0, 3 for placebo (baseline for begge grupper:
d In a second trial in treatment naïve type 2 diabetic obese patients (Serenade), the absolute change in HbA1c (with a baseline of 7.9% for both groups) at six months was -0.8 for rimonabant 20 mg and